Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Mark Coleman
8 Sep 2025
Director
Buy
488
$127.40
$62.17K
Mark Coleman
8 Sep 2025
Director
Buy
287
$127.30
$36.54K
Mark Coleman
8 Sep 2025
Director
Buy
800
$127.20
$101.76K
Roger Jeffs
19 Nov 2021
Director
Buy
3,950
$37.30
$147.35K
Mark Coleman
18 Nov 2021
Director
Buy indirect
1,021
$35.10
$35.84K
Mark Coleman
18 Nov 2021
Director
Buy indirect
409
$35.07
$14.34K
Nick Pizzie
18 Nov 2021
Chief Financial Officer
Buy indirect
142
$35.20
$5.00K
Nick Pizzie
18 Nov 2021
Chief Financial Officer
Buy indirect
145
$34.30
$4.97K
Nick Pizzie
18 Nov 2021
Chief Financial Officer
Buy indirect
141
$35.43
$5.00K
Nick Pizzie
18 Nov 2021
Chief Financial Officer
Buy
527
$35.50
$18.71K
Mark E Saad
17 Nov 2021
Director
Buy indirect
100
$34.40
$3.44K
Mark E Saad
17 Nov 2021
Director
Buy indirect
100
$34.45
$3.45K
Mark E Saad
17 Nov 2021
Director
Buy indirect
100
$34.40
$3.44K
Mark E Saad
17 Nov 2021
Director
Buy
3,000
$34.53
$103.60K
Mark Coleman
12 May 2021
Director
Buy indirect
500
$58.15
$29.08K
Nick Pizzie
29 Jun 2020
Chief Financial Officer
Buy
777
$76.64
$59.55K
Mark Coleman
29 Jun 2020
Director
Buy
650
$78.50
$51.03K
Nick Pizzie
26 Sep 2019
Chief Financial Officer
Buy
2,180
$24.80
$54.06K
Mark Coleman
26 Jun 2019
Director
Buy
15,800
$23.10
$364.98K
Mark Coleman
25 Jun 2019
Director
Buy
400
$23.25
$9.30K
Nick Pizzie
11 Jun 2019
Chief Financial Officer
Buy
1,920
$20.80
$39.94K
Mark E Saad
23 May 2019
Director
Buy
3,500
$22.33
$78.16K
Mark Coleman
13 May 2019
Director
Buy
4,650
$21.44
$99.70K
Mark Coleman
19 Mar 2019
Director
Buy indirect
5,100
$12.18
$62.12K
Nick Pizzie
19 Mar 2019
Chief Financial Officer
Buy
5,340
$12.58
$67.18K
Nick Pizzie
19 Mar 2019
Chief Financial Officer
Buy indirect
60
$12.69
$761.40
Nick Pizzie
19 Jun 2018
Chief Financial Officer
Buy
30,600
$3.10
$94.86K
Nick Pizzie
19 Jun 2018
Chief Financial Officer
Buy
400
$3.05
$1.22K

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 53
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,185,486
History held since 23 Nov 2015